Pacific Hospital Supply Co., Ltd (4126.TWO)
TWD 87.8
(3.05%)
TWD 87.8
(3.05%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 934.33 Million TWD | 0.57% |
| 2022 | 929.03 Million TWD | -14.77% |
| 2021 | 1.09 Billion TWD | -18.29% |
| 2020 | 1.33 Billion TWD | -4.57% |
| 2019 | 1.39 Billion TWD | 9.68% |
| 2018 | 1.27 Billion TWD | -7.54% |
| 2017 | 1.37 Billion TWD | 21.85% |
| 2016 | 1.13 Billion TWD | 72.96% |
| 2015 | 653.96 Million TWD | 63.34% |
| 2014 | 400.37 Million TWD | 16.46% |
| 2013 | 343.77 Million TWD | 0.8% |
| 2012 | 341.04 Million TWD | 27.3% |
| 2011 | 267.89 Million TWD | -8.78% |
| 2010 | 293.67 Million TWD | -18.65% |
| 2009 | 360.98 Million TWD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 907.3 Million TWD | -2.89% |
| 2024 Q2 | 1.25 Billion TWD | 38.78% |
| 2023 Q2 | 1.2 Billion TWD | 31.25% |
| 2023 Q3 | 872.5 Million TWD | -27.36% |
| 2023 FY | 934.33 Million TWD | 0.57% |
| 2023 Q1 | 915.14 Million TWD | -1.49% |
| 2023 Q4 | 934.33 Million TWD | 7.09% |
| 2022 Q1 | 999.59 Million TWD | -8.29% |
| 2022 FY | 929.03 Million TWD | -14.77% |
| 2022 Q4 | 929.03 Million TWD | 3.09% |
| 2022 Q3 | 901.19 Million TWD | -27.38% |
| 2022 Q2 | 1.24 Billion TWD | 24.15% |
| 2021 Q3 | 1.32 Billion TWD | 18.02% |
| 2021 Q1 | 1.21 Billion TWD | -8.93% |
| 2021 Q2 | 1.12 Billion TWD | -7.53% |
| 2021 Q4 | 1.09 Billion TWD | -17.79% |
| 2021 FY | 1.09 Billion TWD | -18.29% |
| 2020 FY | 1.33 Billion TWD | -4.57% |
| 2020 Q3 | 1.34 Billion TWD | -16.28% |
| 2020 Q4 | 1.33 Billion TWD | -0.7% |
| 2020 Q1 | 1.44 Billion TWD | 3.46% |
| 2020 Q2 | 1.6 Billion TWD | 10.94% |
| 2019 Q2 | 1.82 Billion TWD | 10.67% |
| 2019 Q1 | 1.64 Billion TWD | 29.23% |
| 2019 FY | 1.39 Billion TWD | 9.68% |
| 2019 Q3 | 1.74 Billion TWD | -4.09% |
| 2019 Q4 | 1.39 Billion TWD | -20.04% |
| 2018 Q4 | 1.27 Billion TWD | -9.67% |
| 2018 Q3 | 1.41 Billion TWD | -3.87% |
| 2018 FY | 1.27 Billion TWD | -7.54% |
| 2018 Q1 | 1.33 Billion TWD | -3.27% |
| 2018 Q2 | 1.46 Billion TWD | 10.08% |
| 2017 Q4 | 1.37 Billion TWD | -5.41% |
| 2017 Q3 | 1.45 Billion TWD | -6.81% |
| 2017 Q2 | 1.56 Billion TWD | 40.49% |
| 2017 FY | 1.37 Billion TWD | 21.85% |
| 2017 Q1 | 1.11 Billion TWD | -1.6% |
| 2016 FY | 1.13 Billion TWD | 72.96% |
| 2016 Q4 | 1.13 Billion TWD | 12.21% |
| 2016 Q1 | 673.83 Million TWD | 3.04% |
| 2016 Q3 | 1 Billion TWD | 0.74% |
| 2016 Q2 | 1 Billion TWD | 48.48% |
| 2015 Q4 | 653.96 Million TWD | 17.76% |
| 2015 FY | 653.96 Million TWD | 63.34% |
| 2015 Q3 | 555.35 Million TWD | -22.37% |
| 2015 Q2 | 715.34 Million TWD | 108.32% |
| 2015 Q1 | 343.38 Million TWD | -14.23% |
| 2014 Q1 | 325.73 Million TWD | -5.25% |
| 2014 FY | 400.37 Million TWD | 16.46% |
| 2014 Q2 | 518.23 Million TWD | 59.1% |
| 2014 Q4 | 400.37 Million TWD | 14.64% |
| 2014 Q3 | 349.24 Million TWD | -32.61% |
| 2013 Q2 | 631.12 Million TWD | 86.13% |
| 2013 FY | 343.77 Million TWD | 0.8% |
| 2013 Q1 | 339.07 Million TWD | -0.58% |
| 2013 Q3 | 314.62 Million TWD | -50.15% |
| 2013 Q4 | 343.77 Million TWD | 9.27% |
| 2012 Q4 | 341.04 Million TWD | 17.59% |
| 2012 Q1 | 269.53 Million TWD | 0.61% |
| 2012 Q2 | 440.89 Million TWD | 63.58% |
| 2012 Q3 | 290.03 Million TWD | -34.22% |
| 2012 FY | 341.04 Million TWD | 27.3% |
| 2011 Q2 | 480.26 Million TWD | 78.26% |
| 2011 Q1 | 269.41 Million TWD | -8.26% |
| 2011 Q4 | 267.89 Million TWD | 8.0% |
| 2011 FY | 267.89 Million TWD | -8.78% |
| 2011 Q3 | 248.04 Million TWD | -48.35% |
| 2010 Q4 | 293.67 Million TWD | 0.0% |
| 2010 FY | 293.67 Million TWD | -18.65% |
| 2009 FY | 360.98 Million TWD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| St.Shine Optical Co.,Ltd. | 1.61 Billion TWD | 42.26% |
| Bioteque Corporation | 1.43 Billion TWD | 34.673% |
| Chi Sheng Pharma & Biotech Co., Ltd | 547.04 Million TWD | -70.798% |
| Sunder Biomedical Tech. Co., Ltd. | 669.39 Million TWD | -39.579% |
| BenQ Medical Technology Corporation | 2.53 Billion TWD | 63.096% |
| Unicon Optical Co., Ltd. | 568.1 Million TWD | -64.465% |
| Formosa Optical Technology Co.,Ltd. | 4.17 Billion TWD | 77.617% |
| Medeon Biodesign, Inc. | 375.65 Million TWD | -148.724% |
| Concord Medical Co., Ltd. | 470.7 Million TWD | -98.496% |
| Crystalvue Medical Corporation | 221.36 Million TWD | -322.079% |
| Perfect Medical Industry Co., Ltd. | 324.72 Million TWD | -187.735% |
| ICARES Medicus, Inc. | 239.79 Million TWD | -289.633% |
| Lagis Enterprise Co., Ltd. | 304.62 Million TWD | -206.717% |
| Amed Co., Ltd. | 459.81 Million TWD | -103.199% |